| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma
|
Pan, Banglun
|
|
|
72 |
12 |
p. 4103-4119
|
artikel
|
| 2 |
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
|
Dioken, Didem Naz
|
|
|
72 |
12 |
p. 4065-4075
|
artikel
|
| 3 |
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1
|
Deng, Haibin
|
|
|
72 |
12 |
p. 4457-4470
|
artikel
|
| 4 |
A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in mice
|
Pan, Linyue
|
|
|
72 |
12 |
p. 4179-4194
|
artikel
|
| 5 |
Apolipoprotein C-III itself stimulates the Syk/cPLA2-induced inflammasome activation of macrophage to boost anti-tumor activity of CD8+ T cell
|
Hu, Xiangyu
|
|
|
72 |
12 |
p. 4123-4144
|
artikel
|
| 6 |
A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIs
|
Cai, Ruoxue
|
|
|
72 |
12 |
p. 4355-4365
|
artikel
|
| 7 |
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
|
Enell Smith, Karin
|
|
|
72 |
12 |
p. 4145-4159
|
artikel
|
| 8 |
BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex
|
Yao, Bowen
|
|
|
72 |
12 |
p. 4279-4292
|
artikel
|
| 9 |
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents
|
Del Giudice, Maria Livia
|
|
|
72 |
12 |
p. 3931-3937
|
artikel
|
| 10 |
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion
|
Mohankumar, Kumaravel
|
|
|
72 |
12 |
p. 3985-3999
|
artikel
|
| 11 |
Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis
|
Huang, Qingting
|
|
|
72 |
12 |
p. 4077-4088
|
artikel
|
| 12 |
Cholesterol induction in CD8+ T cell exhaustion in colorectal cancer via the regulation of endoplasmic reticulum-mitochondria contact sites
|
Shuwen, Han
|
|
|
72 |
12 |
p. 4441-4456
|
artikel
|
| 13 |
Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren’s syndrome
|
Witkowski Durand Viel, Philine
|
|
|
72 |
12 |
p. 4309-4322
|
artikel
|
| 14 |
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq data reveals dynamic changes in tumor-associated neutrophils in the tumor microenvironment of hepatocellular carcinoma and leads to the establishment of a neutrophil-related prognostic model
|
Yang, Dashuai
|
|
|
72 |
12 |
p. 4323-4335
|
artikel
|
| 15 |
Correction to: A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma
|
Pan, Banglun
|
|
|
72 |
12 |
p. 4121-4122
|
artikel
|
| 16 |
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma
|
Tachiki, Lisa May Ling
|
|
|
72 |
12 |
p. 4471
|
artikel
|
| 17 |
Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer
|
Li, Ningjing
|
|
|
72 |
12 |
p. 3939-3952
|
artikel
|
| 18 |
Esophageal cancer cell-derived small extracellular vesicles decrease circulating Tfh/Tfr via sEV-PDL1 to promote immunosuppression
|
Li, Zijie
|
|
|
72 |
12 |
p. 4249-4259
|
artikel
|
| 19 |
Evaluation of neoadjuvant chemotherapy combined with PD-1 inhibitors in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma: a comparative study of antitumor activity
|
Xu, Pengfei
|
|
|
72 |
12 |
p. 4209-4219
|
artikel
|
| 20 |
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor
|
McCarthy, Derrick
|
|
|
72 |
12 |
p. 4195-4207
|
artikel
|
| 21 |
GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma
|
Qin, Lijuan
|
|
|
72 |
12 |
p. 4337-4354
|
artikel
|
| 22 |
HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells
|
Kansy, Benjamin A.
|
|
|
72 |
12 |
p. 4367-4383
|
artikel
|
| 23 |
Human anaerobic microbiome: a promising and innovative tool in cancer prevention and treatment by targeting pyruvate metabolism
|
Om, Hari
|
|
|
72 |
12 |
p. 3919-3930
|
artikel
|
| 24 |
Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia
|
Peng, Qian
|
|
|
72 |
12 |
p. 4399-4414
|
artikel
|
| 25 |
Intensified NK cell therapy in combination with low-dose chemoradiotherapy against human colorectal cancer
|
Nguyen, Huy Phuoc Quang
|
|
|
72 |
12 |
p. 4089-4102
|
artikel
|
| 26 |
Organ-on-a-chip models for development of cancer immunotherapies
|
Chernyavska, M.
|
|
|
72 |
12 |
p. 3971-3983
|
artikel
|
| 27 |
PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
|
Lin, Ke Xin
|
|
|
72 |
12 |
p. 3875-3893
|
artikel
|
| 28 |
PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
|
Fang, Qi
|
|
|
72 |
12 |
p. 4161-4168
|
artikel
|
| 29 |
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer
|
Zwart, Eline S.
|
|
|
72 |
12 |
p. 4385-4397
|
artikel
|
| 30 |
Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome
|
Minz, Aliva Prity
|
|
|
72 |
12 |
p. 4261-4278
|
artikel
|
| 31 |
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
|
Wahid, Mussarat
|
|
|
72 |
12 |
p. 4001-4014
|
artikel
|
| 32 |
The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression
|
Annels, Nicola E.
|
|
|
72 |
12 |
p. 4221-4234
|
artikel
|
| 33 |
The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer
|
Shen, Ziyun
|
|
|
72 |
12 |
p. 4235-4247
|
artikel
|
| 34 |
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients
|
Chmielewska, Izabela
|
|
|
72 |
12 |
p. 4169-4177
|
artikel
|
| 35 |
The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma
|
Kou, Liqiu
|
|
|
72 |
12 |
p. 3953-3969
|
artikel
|
| 36 |
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition
|
van Eijs, Mick J. M.
|
|
|
72 |
12 |
p. 4049-4064
|
artikel
|
| 37 |
Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies
|
Luo, Yan
|
|
|
72 |
12 |
p. 4031-4047
|
artikel
|
| 38 |
Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
|
Zhu, Liya
|
|
|
72 |
12 |
p. 3895-3917
|
artikel
|
| 39 |
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer
|
Hu, Qin
|
|
|
72 |
12 |
p. 4293-4308
|
artikel
|
| 40 |
Tumor immunology meets oncology (TIMO) XVII, April 20–22 2023 in Halle/Saale, Germany
|
Seliger, Barbara
|
|
|
72 |
12 |
p. 4431-4439
|
artikel
|
| 41 |
Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis
|
Ge, Ling-Ling
|
|
|
72 |
12 |
p. 4415-4429
|
artikel
|
| 42 |
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models
|
Wang, Bochun
|
|
|
72 |
12 |
p. 4015-4030
|
artikel
|
Tijdschrift beschrijving